Avidity Biosciences, Inc.
RNA
$26.57
-$1.53-5.45%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 27.27% | 14.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 27.27% | 14.23% | |||
| Cost of Revenue | 23.87% | 20.73% | |||
| Gross Profit | -23.77% | -20.95% | |||
| SG&A Expenses | 21.76% | 12.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.38% | 18.66% | |||
| Operating Income | -23.29% | -18.77% | |||
| Income Before Tax | -27.19% | -13.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -27.19% | -13.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -27.19% | -13.57% | |||
| EBIT | -23.29% | -18.77% | |||
| EBITDA | -23.43% | -18.90% | |||
| EPS Basic | -22.11% | 1.57% | |||
| Normalized Basic EPS | -22.12% | 1.57% | |||
| EPS Diluted | -22.11% | 1.57% | |||
| Normalized Diluted EPS | -22.12% | 1.57% | |||
| Average Basic Shares Outstanding | 4.15% | 15.38% | |||
| Average Diluted Shares Outstanding | 4.15% | 15.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
